Andrea Califano began his career as a physicist. But that's not why he's now calling cancer a quantum disease. "We're really just following the data," says Califano, the Clyde '56 and Helen Wu Professor of Chemical Biology ...
Aug 26, 2026
0
1567
Inspired by the work of the RNA Therapeutics Institute at UMass Chan Medical School and the development of the COVID vaccine, Marcus Ruscetti, Ph.D., and Chaitanya Naimesh Parikh, Ph.D. '26, have developed an immunotherapy ...
Aug 25, 2026
0
497
Men with prostate cancer have a high risk of heart disease, especially when treated with hormone therapy. A large international, first-of-its-kind study led by Hamilton researchers found that routine referrals to an internist ...
Aug 30, 2026
0
389
Recent discoveries have revealed that breast cancer cells are more flexible than previously thought. Some can change from a differentiated state, when a mature cell has taken on a specific function, back to a more stem-like ...
A new review by a team of researchers from Indonesia, Japan and China, led by Professor Nurhasni Hasan from the Faculty of Pharmacy at Hasanuddin University in Indonesia, examines how emerging local drug delivery systems ...
Aug 26, 2026
0
327
When added to standard chemotherapy, a clinical version of the dietary supplement L-glutamine improved survival in an early-phase trial of patients with advanced pancreatic cancer. The study, led by Cedars-Sinai Health Sciences ...
Sep 1, 2026
0
134
Bladder cancer claims 220,000 lives globally each year, with symptoms sometimes mistaken for other conditions such as kidney stones. Now researchers have developed an artificial intelligence system that can identify bladder ...
Aug 25, 2026
0
84
Patients with sickle cell disease are often hesitant to undergo transformative gene therapy—the current lengthy process requires multiple hospital visits to collect enough stem cells. Researchers from Boston Children's Hospital ...
Aug 25, 2026
0
47
The immune system possesses legions of T cells that, if primed, could hunt down and destroy tumors. Now, a UC San Francisco team has invented a way to do this by combining immune cells grown in the lab with samples from a ...
Aug 25, 2026
0
43
A new phase 1 clinical trial has found that an emerging immunotherapy is promising for treating recurrent glioblastoma, a highly aggressive and fatal brain cancer. Chimeric antigen receptor T (CAR-T) cell therapy is a form ...
Aug 31, 2026
0
40
